Delivery Order SPE2DB22D2007-SPE2DB25FJ2NR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This firm fixed-price delivery order, valued at $11,775.31, represents a competitively awarded contract with an ultimate completion date of August 29, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside designation applied to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This competitively awarded, non-set-aside order carries a firm fixed price of $13,340.29 and is scheduled for completion by June 17, 2025. The products will be delivered to the company's headquarters in Conshohocken, Pennsylvania, and serve federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 24,000 units of Creon DR 100s capsules, a pancreatic enzyme supplement medication. This competitively awarded, non-set-aside contract carries a ceiling value of $3,042.77 and is classified as a firm fixed price delivery order with an ultimate completion date of August 27, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Creon DR 36,000 unit capsules in units of 100, with a contract ceiling value of $2,335.13 and an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of 12,000 unit capsules of Creon DR 100s, with a ceiling value of $3,797.77. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency issued a delivery order valued at $14,994.54 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packages. This firm fixed-price delivery order, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical will be supplied from the vendor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy, with a contract ceiling value of $14,334.96. This competitive, non-set-aside delivery order is firm fixed price with an ultimate completion date of November 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy medication. This firm fixed-price delivery order, valued at $5,910.78, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is non-competitive set-aside and will be performed at the vendor's corporate office location...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2NRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy medication. This firm fixed-price delivery order, valued at $1,856.40, was issued without a set-aside designation and is scheduled for completion by June 26, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The competitively awarded contract reflects AmerisourceBergen's established capability as a major pharmaceutical distributor meeting federal procurement requirements for critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/25/25 |